Comment on "not lipoteichoic acid but lipoprotéine appear to be the dominant immunobiologically active compounds in Staphylococcus aureus" [3]

Journal of Immunology

Volumn 178, Issue 5, 2007, Pages 2610-

  Von Aulock, Sonja ^a   Hartung, Thomas ^a   Hermann, Corinna ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN; LIPOTEICHOIC ACID;

CELL ACTIVATION; IMMUNOGENICITY; IMMUNOSTIMULATION; LETTER; MACROPHAGE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ACYLTRANSFERASES; ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL LINE; HYDROPHOBICITY; LIPOPOLYSACCHARIDES; LIPOPROTEINS; MICE; MUTATION; NF-KAPPA B; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33847361765     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Hashimoto, M. K. Tawaratsumida, H. Kariya, A. Kiyohara, Y. Suda, F. Krikae, T. Kirikae, and F. Gotz. 2006. Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J. Immunol. 177:3162-3169.
2. Morath, S., A. Geyer, and T. Hartung. 2001. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J. Exp. Med. 193: 393-397.
3. Morath, S., A. Stadelmaier, A. Geyer, R. R. Schmidt, and T. Hartung. 2002. Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J. Exp. Med. 195:1635-1640.
4. Deininger, S., A. Stadelmaier, S. von Aulock, S. Morath, R. R. Schmidt, and T. Hartung. 2003. Definition of structural prerequisites for lipoteichoic acid-inducible cytokine induction by synthetic derivatives. J. Immunol. 170: 4134-4138.
5. Morath, S., A. Geyer, I. Spreitzer, C. Hermann, and T. Hartung. 2002. Structural decomposition and heterogeneity of commercial lipoteichoic acid preparations. Infect. Immun. 70: 938-944.